A Long-term Clinical and Radiographic Outcome of Carotid-ophthalmic Aneurysm with Enterprise Stent-assisted Coiling Embolization

Heng YANG,Jia-bin SU,Yu LEI,Bing LENG,Bin XU,Gong CHENG,Yan-long TIAN,Yu-xiang GU
DOI: https://doi.org/10.3969/j.issn.1008-0678.2017.06.002
2017-01-01
Abstract:Aim To research the outcome of Enterprise stent-assisted coiling embolization for carotid-ophthalmic aneurysm. Methods From January 2011 to December 2015,100 consecutive patients with 104 carotid-ophthalmic aneurysms were treated with Enterprise stent-assisted embolization. The clinical and radiographic outcomes of those patients were respectively reviewed. Results Of those 104 carotid-ophthalmic aneurysms, there were 77 small aneurysms, 27 large aneurysms and no aneurysm larger than 25 mm. According to aneurysm classification, 36 aneurysms were ophthalmic aneurysm (typeⅠ) and 68 aneurysms belonged to superior artery aneurysm (typeⅡ). 94% patients have achieved clinical fellow-up, which showed good outcome (mRS 0-2) was achieved in 97.8% patients at the last fellow-up and 82%patients attained radiographic fellow-up, and 7 aneurysms were neck recurrence and 4 aneurysms were recanalized at last follow-up. The complication rate was 8.0%, including thromb embolism in three patients, coil prolapsed in two patients, vasospasm in two patients and intracranial hemorrhage in one patient. According to univariate analysis, the aneurysm size associated with incomplete occlusion (P=0.000) and multivariable analysis demonstrated incomplete occlusion was related to aneurysm recurrence (P=0.038). Conclusion Enterprise stent-assisted coiling embolization was a safe and effective treatment method for carotid-ophthalmic aneurysm. The larger aneurysm was more difficult to embolise completely and had a high rate of aneurysm recurrence.
What problem does this paper attempt to address?